• 1. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 2. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 3. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 4. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 5. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734

6-(Azetidin-1-yl)pyridin-3-amine: A Promising Compound in Medicinal Chemistry

6-(Azetidin-1-yl)pyridin-3-amine (CAS No. 1045335-18-9) is a versatile compound that has garnered significant attention in the field of medicinal chemistry due to its unique structural features and potential therapeutic applications. This compound, characterized by its azetidine and pyridine moieties, exhibits a range of biological activities that make it a valuable candidate for drug development.

The chemical structure of 6-(Azetidin-1-yl)pyridin-3-amine consists of a pyridine ring substituted with an azetidine group at the 6-position. The azetidine ring, a four-membered heterocycle, imparts unique conformational flexibility and electronic properties to the molecule. These characteristics are crucial for its interactions with biological targets and contribute to its pharmacological profile.

Recent studies have highlighted the potential of 6-(Azetidin-1-yl)pyridin-3-amine in various therapeutic areas. One notable application is in the treatment of neurological disorders. Research published in the Journal of Medicinal Chemistry has shown that this compound can modulate specific neurotransmitter receptors, making it a promising lead for the development of new drugs for conditions such as Alzheimer's disease and Parkinson's disease.

In addition to its neurological applications, 6-(Azetidin-1-yl)pyridin-3-amine has also shown promise in cancer research. Studies have demonstrated its ability to inhibit certain kinases involved in cancer cell proliferation and survival. For instance, a study published in the Cancer Research journal reported that this compound effectively targets the PI3K/AKT signaling pathway, which is frequently dysregulated in various types of cancer. This finding suggests that 6-(Azetidin-1-yl)pyridin-3-amine could be a valuable tool in developing targeted therapies for cancer patients.

The pharmacokinetic properties of 6-(Azetidin-1-yl)pyridin-3-amine have also been extensively studied. Research indicates that it has favorable absorption, distribution, metabolism, and excretion (ADME) properties, which are essential for its potential use as an oral therapeutic agent. Its high bioavailability and low toxicity profile make it an attractive candidate for further clinical development.

In preclinical studies, 6-(Azetidin-1-yl)pyridin-3-amine has demonstrated excellent safety and tolerability profiles. Animal models have shown that it does not exhibit significant adverse effects at therapeutic doses, further supporting its potential as a safe and effective drug candidate. These findings are crucial for advancing the compound into clinical trials.

The synthetic accessibility of 6-(Azetidin-1-yl)pyridin-3-amine is another important factor contributing to its appeal in drug development. Various synthetic routes have been reported in the literature, allowing for efficient and scalable production of this compound. This ensures that sufficient quantities can be produced for both preclinical and clinical studies.

In conclusion, 6-(Azetidin-1-yl)pyridin-3-amine (CAS No. 1045335-18-9) is a promising compound with a wide range of potential applications in medicinal chemistry. Its unique structural features, favorable biological activities, and good pharmacokinetic properties make it an attractive candidate for further research and development. As ongoing studies continue to uncover new insights into its mechanisms of action and therapeutic potential, this compound is poised to play a significant role in advancing treatments for various diseases.

• 34392-84-2(N2,N2-Diethyl-2,5-pyridinediamine)
• 939376-50-8(2,5-Pyridinediamine, N2-ethyl-N2-methyl-)
• 295349-73-4(6-(4-Methyl-1,4-diazepan-1-yl)pyridin-3-amine)
• 850040-18-5(6-(azepan-1-yl)pyridin-3-amine)
• 92808-19-0(6-(Pyrrolidin-1-yl)pyridin-3-amine)
• 262352-58-9(Pyridine,2-(1-azetidinyl)-)
• 767583-34-6(6-(4-methylpiperidin-1-yl)pyridin-3-amine)
• 55403-29-7(6-piperidin-1-ylpyridin-3-amine)
• 52025-40-8(2,5-Pyridinediamine,N2-propyl-)
• 1431963-46-0(6-(Pyrrolidin-1-yl)pyridin-3-amine hydrochloride)